SBL
GRTS

Sargent Bickham Lagudis’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Sargent Bickham Lagudis’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-361
Closed -$3K – 1006
2021
Q2 		$3K Hold
361
– – ﹤0.01% 853
2021
Q1 		$3K Buy
+361
New +$4.97K ﹤0.01% 847

Other funds holding GRTS

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Sargent Bickham Lagudis's GRTS Position: Q3 2021 in Review

Sargent Bickham Lagudis sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q3 2021, closing a stake of 361 shares — an estimated $3K sold.

Sargent Bickham Lagudis first reported a position in GRTS in Q1 2021 and held it in 2 quarters. The position peaked at $3K in Q2 2021. 92 funds tracked by Wall St. Rank hold GRTS as of Q3 2021.

  • Sargent Bickham Lagudis reported no remaining Gritstone bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Sargent Bickham Lagudis sold 361 Gritstone bio, Inc. Common Stock shares in Q3 2021, an estimated $3K.
  • Sargent Bickham Lagudis first reported a position in Gritstone bio, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Sargent Bickham Lagudis's Gritstone bio, Inc. Common Stock position peaked at $3K in Q2 2021.
  • 92 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q3 2021.

Based on Sargent Bickham Lagudis's 13F filing for Q3 2021, filed 5 Nov 2021.